<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="UTF-8" />
  <meta name="viewport" content="width=device-width, initial-scale=1.0" />
  <title>Radionuclide Therapies | NY Imaging Specialists</title>

  <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/6.4.0/css/all.min.css" />
  <link rel="stylesheet" href="https://use.typekit.net/ike4wxa.css" />
  <link rel="stylesheet" href="/css/styles.css" />
  <link rel="stylesheet" href="/css/header2.css" />
    <link rel="stylesheet" href="/css/footer.css" />
</head>
<body>

  <!-- Header (loaded by components.js) -->
  <div id="header-placeholder"></div>

  <!-- Page Hero -->
  <section class="page-hero">
    <div class="page-hero-overlay"></div>
    <div class="container">
      <nav class="breadcrumb">
        <a href="/">Home</a>
        <i class="fas fa-chevron-right"></i>
        <a href="/services">Services</a>
        <i class="fas fa-chevron-right"></i>
        <span>Radionuclide Therapies</span>
      </nav>
      <h1>Radionuclide Therapies</h1>
      <p class="hero-subtitle">
        Targeted radiopharmaceutical treatments designed to deliver therapeutic radiation to tumors while helping to spare healthy tissues.
      </p>
    </div>
  </section>

  <!-- Overview -->
  <section class="section section-white">
    <div class="container">
      <div class="content-image-grid">
        <div class="content-block">
          <h2>What are Radionuclide Therapies?</h2>
          <p>
            Radionuclide therapies utilize radiopharmaceutical drugs that target specific types of tumors. Releasing energy, these drugs can bring radiation to tumors in targeted doses and therefore sparing normal and healthy tissues.
          </p>
          <p>
            A radiopharmaceutical consists of a radioisotope ion bonded to an organic molecule, which in turn conveys the radioisotope to the targeted organ, tissue, or cell.
            The choice of the radioisotope depends on the affinity or binding power to target structures of the tumor such as antigens and receptors.
          </p>
          <p>
            The radiation from the radioactive nuclide damages the DNA of the cancer cells, killing them in the process and shrinking the tumors.
            Radiopharmaceuticals not only effectively eliminate malignant tumor cells but also help spare healthy tissues and organs.
          </p>
        </div>

        <div class="image-block">
          <img src="https://images.unsplash.com/photo-1582719478185-2f3b6fd1f8b6?w=900" alt="Medical infusion and oncology care" />
        </div>
      </div>
    </div>
  </section>

  <!-- How it Works -->
  <section class="section section-light">
    <div class="container">
      <h2 class="section-heading">How It Works</h2>
      <p class="section-subheading">
        Radionuclide therapy uses carefully selected radioisotopes to deliver therapeutic radiation to targeted tissues.
      </p>

      <div class="process-steps">
        <div class="process-step">
          <span class="step-number">1</span>
          <h4>Targeting</h4>
          <p>A radioisotope is bonded to a carrier molecule that can travel to a specific organ, tissue, or tumor target.</p>
        </div>
        <div class="process-step">
          <span class="step-number">2</span>
          <h4>Delivery</h4>
          <p>The radiopharmaceutical is typically administered intravenously, allowing it to circulate and bind where intended.</p>
        </div>
        <div class="process-step">
          <span class="step-number">3</span>
          <h4>Therapeutic Effect</h4>
          <p>
            The ionizing radiation emitted by the radionuclide determines the biological activity of the radiopharmaceutical.
            Tumor therapy typically uses alpha or beta emitters, which deliver radiation into nearby tissues.
          </p>
        </div>
        <div class="process-step">
          <span class="step-number">4</span>
          <h4>Follow-Up</h4>
          <p>Your care team will review response and symptoms and guide next steps based on your diagnosis and treatment plan.</p>
        </div>
      </div>

      <div class="callout-box mt-5">
        <h3><i class="fas fa-shield-heart"></i> Important Note</h3>
        <p>
          We strongly encourage you to talk with your health care professional about your specific medical condition and treatments.
          The information on this page is meant to be helpful and educational but is not a substitute for medical advice.
        </p>
      </div>
    </div>
  </section>

  <!-- Therapies -->
  <section class="section section-white">
    <div class="container">
      <h2 class="section-heading">Radionuclide Therapies</h2>
      <p class="section-subheading">Treatments may be used for palliation or therapy depending on diagnosis and care plan.</p>

      <div class="grid grid-cols-2">
        <div class="prep-card">
          <h4><i class="fas fa-hand-holding-heart"></i> Palliatives</h4>
          <div class="mt-3">
            <h5 style="margin: 0 0 8px 0;">Xofigo</h5>
            <p style="margin: 0;">
              Xofigo is a radioactive agent used for the treatment of prostate cancer with metastatic bone disease.
              It is administered intravenously as a slow injection over a minute. Injections are performed monthly over the course of 6 months.
            </p>
          </div>
          <div class="mt-4">
            <h5 style="margin: 0 0 8px 0;">Quadramet</h5>
            <p style="margin: 0;">
              Quadramet is an injectable radiopharmaceutical for treating bone pain associated with various cancer types. Given as a single injection.
              It can be repeated if your physician determines it may benefit symptom relief.
            </p>
          </div>
        </div>

        <div class="prep-card">
          <h4><i class="fas fa-crosshairs"></i> Therapeutic</h4>
          <div class="mt-3">
            <h5 style="margin: 0 0 8px 0;">Zevalin</h5>
            <p style="margin: 0;">
              Zevalin is a treatment for Follicular Lymphoma that combines two effective therapies in a single course of treatment: immunotherapy and radiotherapy.
              The entire treatment regimen can be completed in 7-9 days. It is administered intravenously.
            </p>
          </div>

          <div class="warning-box mt-4">
            <h3><i class="fas fa-exclamation-triangle"></i> Care Planning</h3>
            <p>
              Eligibility, preparation, and aftercare are individualized. Your provider will review your medical history and treatment goals to determine the most appropriate approach.
            </p>
          </div>
        </div>
      </div>
    </div>
  </section>

  <!-- Why Choose NYI (loaded by components.js) -->
  <div id="why-choose-nyi-placeholder"></div>

  <!-- CTA -->
  <section class="provider-cta-section">
    <div class="cta-content">
      <h2>Questions or Ready to Schedule?</h2>
      <p>
        Call to speak with our team or book online to get started with imaging and treatment coordination.
      </p>
      <div class="cta-buttons">
        <a href="tel:833-269-4624" class="btn btn-white">
          <i class="fas fa-phone"></i> Call 833-269-4624
        </a>
        <a href="/appointments" class="btn btn-outline">
          <i class="fas fa-calendar-alt"></i> Book Online
        </a>
      </div>
    </div>
  </section>

  <!-- Footer (loaded by components.js) -->
  <div id="footer-placeholder"></div>

  <!-- JavaScript -->
  <script src="/js/navigation.js"></script>
  <script src="/js/components.js"></script>
  <script src="/js/header-scroll.js"></script>

</body>
</html>
